CAPGEMINI_REGISTRATION_DOCUMENT_2017

4

FINANCIAL INFORMATION

4.2 Consolidated Financial Statements

{

2017 International Plans

Maximum number of shares that may be granted

1,691,496{shares

1,691,496{shares

% of share capital at the date of the Board of Directors’ decision

1%

1%

Total number of shares granted Date of Board of Directors’ decision Performance assessment dates

63,597{ (8)

1,522,500{ (3)

July{26, 2017

October{5, 2017

Presence condition only

Three years for the two conditions

Vesting period

3{years and 1{week as from the grant date (other countries)

3{years as from the grant date (France) or 4{years as from the grant date (other countries)

Mandatory lock-in period effective as from the vesting date (France only)

n/a

2{years

Main market conditions at the grant date Volatility ■

n/a

25.65%

Risk-free interest rate Expected dividend rate

-0.25% / -0.04%

-0.17%/ +0.90%

■

1.60%

1.60%

■

Other conditions

Yes (see below)

Performance conditions

■

Employee presence within the Group at the vesting date ■ Pricing model used to calculate the fair value of shares

Yes

Monte Carlo for performance shares with external (market) conditions

Range of fair values (in euros) Free shares (per share and in euros) ■

89.05

86.98 – 93.25 62.02 – 93.25

Performance shares (per share and in euros) ■

n/a

Of which corporate officers

-

66.38

Number of shares at December{31, 2016

that may vest under the plan in respect of shares previously granted, subject to conditions (performance and/or presence) - - o/w to corporate officers - -

Change during the period

Number of shares subject to performance and/or presence conditions granted during the year 63,597

1,522,500

o/w to corporate officers -

35,000{ (1)

Number of shares forfeited or canceled during the year -

17,300

Number of shares vested during the year -

-

Number of shares at December{31, 2017

that may vest under the plan in respect of shares previously granted, subject to conditions (performance and/or presence) 63,597{ (8) 1,505,200{ (9)

Weighted average number of shares Share price at the grant date (in euros)

26,499

378,463

94.20

100.25

Grant subject to performance conditions only. (1) In respect of the “foreign” plan only. (2) Grant subject to performance conditions only, except for 19,150{shares subject to presence conditions only. (3)

Of which 337,316{shares in respect of the “French” plan and 618,282{shares in respect of the “foreign” plan; these amounts include a 4% discount on the external performance condition (4) as the performance of the Capgemini{SE share compared with the basket of comparable securities and the CAC{40 index is between 109{and 110% of the average performance of the basket.

Grant subject to presence conditions only for beneficiaries employed by IGATE, acquired on July{1, 2015. (5) Of which 7,500{shares in respect of the “French” plan and 136,550{shares in respect of the “foreign” plan. (6) Of which 441,350{shares in respect of the “French” plan and 1,133,700{shares in respect of the “foreign” plan. (7) Grant subject to presence conditions only for beneficiaries employed by Idean, acquired in February{2017. (8) Of which 456,400{shares in respect of the “French” plan and 1,048,800 shares in respect of the “foreign” plan. (9)

204

REGISTRATION DOCUMENT 2017 — CAPGEMINI